Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn.
Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang CT.
Davidson D, et al. Among authors: kattwinkel j.
Pediatrics. 1999 Aug;104(2 Pt 1):231-6. doi: 10.1542/peds.104.2.231.
Pediatrics. 1999.
PMID: 10429000
Clinical Trial.
Change in oxygenation and outcome (death and/or extracorporeal membrane oxygenation) during or immediately after withdrawing I-NO were the principal endpoints. Patients (n = 155) were term infants, <3 days old at study entry with echocardiographic evidence of persistent …
Change in oxygenation and outcome (death and/or extracorporeal membrane oxygenation) during or immediately after withdrawing I-NO were the p …